Intco Medical Technology Hits Day Low of CNY 54.42 Amid Price Pressure

Intco Medical Technology Co., Ltd. experienced a notable decline today, with the stock dropping by 4.72% on March 26, 2026. The stock reached an intraday low of CNY 54.42, reflecting a challenging trading session. Despite this downturn, the company has shown strong performance metrics over various time frames. In the past year, Intco Medical has achieved a remarkable return of 123.85%, significantly outperforming the China Shanghai Composite, which reported a gain of 15.45%. The company's year-to-date performance stands at 40.64%, contrasting with the composite's decline of 2.01%. Financially, Intco Medical boasts a robust operating cash flow of CNY 2,119.78 million and a return on capital employed (ROCE) of 9.77%. The company has also reported a decrease in raw material costs by 10.74% year-over-year, contributing to its operational efficiency. With a price-to-book ratio of 1.37 and a dividend yield of 0.39%, Intco Medical maintains a solid market position within the pharmaceuticals and biotechnology sector.